{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:52:52Z","timestamp":1790301172491,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dutch Ministry of Economic Affairs"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.ijpharm.2014.12.014","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T15:00:51Z","timestamp":1418310051000},"page":"99-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biocompatibility of poly(d,l-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injection"],"prefix":"10.1016","volume":"482","author":[{"given":"F.","family":"Kazazi-Hyseni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zandstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.R.","family":"Popa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Goldschmeding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.R.","family":"Lathuile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.","family":"Veldhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.F.","family":"Van Nostrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.E.","family":"Hennink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4933-3968","authenticated-orcid":false,"given":"R.J.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2014.12.014_bib0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.matsci.31.1.81","article-title":"Biological responses to materials","volume":"31","author":"Anderson","year":"2001","journal-title":"Annu. Rev. Mater Sci."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Anderson","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0142-9612(96)85754-1","article-title":"Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid\/polyglycolic acid copolymers","volume":"17","author":"Athanasiou","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0379-0738(91)90083-U","article-title":"Nuclear magnetic resonance identification and estimation of solvent residues in cocaine","volume":"49","author":"Avdovich","year":"1991","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0025","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02038235","article-title":"Comparison of the catalogues of the k0-and the kZn single comparator methods for standardization in INAA","volume":"191","author":"Blaauw","year":"1995","journal-title":"J. Radioanal. Nucl. Chem. Art."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/1097-4636(20010915)56:4<600::AID-JBM1133>3.0.CO;2-I","article-title":"A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic) acid after subcutaneous injection in rats","volume":"56","author":"Cad\u00e9e","year":"2001","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0035","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","article-title":"Role of particle size in phagocytosis of polymeric microspheres","volume":"25","author":"Champion","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0040","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1016\/j.biomaterials.2012.03.052","article-title":"Development and in-vivo characterization of supramolecular hydrogels for intrarenal drug delivery","volume":"33","author":"Dankers","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0045","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0142-9612(00)00266-0","article-title":"In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts","volume":"22","author":"De Groot","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0050","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/01.LAB.0000101911.53973.90","article-title":"Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis","volume":"83","author":"Desmouli\u00e8re","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0055","first-page":"589","article-title":"The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3","volume":"54","author":"Dijkstra","year":"1985","journal-title":"Immunology"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0060","series-title":"Guideline on the Specification Limits for Residues of Metal Catalysts","author":"EMEA","year":"2007"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0065","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/jps.20625","article-title":"BSA degradation under acidic conditions: a model for protein instability during release from PLGA delivery systems","volume":"95","author":"Estey","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0070","unstructured":"FDA Guidance Documents, December, 1997. International Conference on Harmonization (ICH) \u2013 Guidance for Industry: Q3C Impurities: Residual Solvents."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2009.04.025","article-title":"Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid)","volume":"138","author":"Ghassemi","year":"2009","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0080","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s11095-010-0205-8","article-title":"Hydrophilic polyester microspheres: effect of molecular weight and copolymer composition on release of BSA","volume":"27","author":"Ghassemi","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0085","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11095-011-0517-3","article-title":"Controlled release of octreotide and assessment of peptide acylation from poly(d,l-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres","volume":"29","author":"Ghassemi","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0090","first-page":"3","article-title":"Organic solvents in the pharmaceutical industry","volume":"67","author":"Grodowska","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1023\/B:PHAM.0000029275.41323.a6","article-title":"Structure\u2013immunogenicity relationships of therapeutic proteins","volume":"21","author":"Hermeling","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0100","first-page":"813","article-title":"Development of Yersinia pestis F1 antigen-loaded microspheres vaccine against plague","volume":"9","author":"Huang","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0105","unstructured":"ISO Guidelines, April 23, 2013. Biological Evaluation of Medical Devices Part 1: Evaluation and Testing, International Standard ISO-10993 (draft guidance for FDA)."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0115","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mrc.1578","article-title":"1H and 13C NMR data to aid the identification and quantification of residual solvents by NMR spectroscopy","volume":"43","author":"Jones","year":"2005","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0120","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.4161\/hv.26136","article-title":"Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses","volume":"9","author":"Joshi","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0125","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s11095-014-1381-8","article-title":"Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months","volume":"31","author":"Kazazi-Hyseni","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0130","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.1166\/jnn.2011.4496","article-title":"Development of a biodegradable sirolimus-eluting stent coated by ultrasonic atomizing spray","volume":"11","author":"Kim","year":"2011","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0135","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jbm.1261","article-title":"Biocompatibility of lipid\u2013protein\u2013sugar particles containing bupivacaine in the epineurium","volume":"59","author":"Kohane","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0140","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00022744-199812000-00010","article-title":"Low-temperature heating overnight in Tris-HCl buffer pH 9 is a good alternative for antigen retrieval in formalin-fixed paraffin-embedded tissue","volume":"6","author":"Koopal","year":"1998","journal-title":"Appl. Immunohistochem."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0145","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1021\/bm700476h","article-title":"In vitro hydrolytic degradation of hydroxyl-functionalized poly(alpha-hydroxy acid)s","volume":"8","author":"Leemhuis","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0150","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1021\/ma052128c","article-title":"Functionalized poly(a-hydroxy acid)s via ring-opening polymerization: toward hydrophilic polyesters with pendant hydroxyl groups","volume":"39","author":"Leemhuis","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0155","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1016\/j.biomaterials.2012.06.013","article-title":"The microclimate pH in poly(d,l-lactide-co-hydroxymethyl glycolide) microspheres during biodegradation","volume":"33","author":"Liu","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0160","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.actbio.2014.01.033","article-title":"Polymeric nanoparticles for pulmonary protein and DNA delivery","volume":"10","author":"Menon","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0169-409X(00)00099-5","article-title":"Particle control of emulsion by membrane emulsification and its applications","volume":"45","author":"Nakashima","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0170","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0168-3659(94)00084-8","article-title":"Importance of in vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly (d,l-lactic acid-co-glycolic acid) microspheres","volume":"33","author":"Park","year":"1995","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0175","first-page":"81","article-title":"The immunogenicity of biopharmaceuticals. Lessons learned and consequences for protein drug development","volume":"112","author":"Patten","year":"2003","journal-title":"Dev. Biol. (Basel)"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0180","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0003-9861(62)90161-3","article-title":"Formotion of serine and glyceric acid by the glycolate pathway","volume":"98","author":"Rabson","year":"1962","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0185","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.biomaterials.2013.12.001","article-title":"Implantable controlled release devices for BMP-7 delivery and suppression of glioblastoma initiating cells","volume":"35","author":"Reguera-Nu\u00f1ez","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0190","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jconrel.2013.05.034","article-title":"The effect of lauryl capping group on protein release and degradation of poly(d,l-lactic-co-glycolic acid) particles","volume":"172","author":"Samadi","year":"2013","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0195","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1021\/bm301900t","article-title":"Mechanistic studies on the degradation and protein release characteristics of poly(lactic-co-glycolic-co-hydroxymethylglycolic acid) nanospheres","volume":"14","author":"Samadi","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0200","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s10856-007-3345-6","article-title":"Biocompatibility of polyhydroxybutyrate microspheres: in vitro and in vivo evaluation","volume":"19","author":"Shishatskaya","year":"2008","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0205","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1016\/j.biomaterials.2013.06.044","article-title":"Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide","volume":"34","author":"Shmueli","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0210","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1083\/jcb.103.6.2787","article-title":"A monoclonal antibody against a-smooth muscle actin: a new probe for smooth muscle differentiation","volume":"103","author":"Skalli","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0215","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0142-9612(89)90063-X","article-title":"In vitro and in vivo degradation of poly(d,l lactide\/glycolide) type microspheres made by solvent evaporation method","volume":"10","author":"Spenlehauer","year":"1989","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0220","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0142-9612(88)90033-6","article-title":"Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage","volume":"9","author":"Tabata","year":"1988","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0225","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-3659(96)01363-6","article-title":"Tetanus toxoid and synthetic malaria antigen containing poly(lactide)\/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response","volume":"41","author":"Thomasin","year":"1996","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0230","doi-asserted-by":"crossref","first-page":"13226","DOI":"10.1021\/ja0459936","article-title":"Raman imaging of PLGA microsphere degradation inside macrophages","volume":"126","author":"Van Apeldoorn","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0235","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0142-9612(94)90271-2","article-title":"Biodegradation of PLA\/GA polymers: increasing complexity","volume":"15","author":"Vert","year":"1994","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0240","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/088532828700200103","article-title":"Tissue response to biodegradable injectable microcapsules","volume":"2","author":"Visscher","year":"1987","journal-title":"J. Biomate. Appl."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0245","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jbm.820220806","article-title":"Effect of particle size on the in vitro and in vivo degradation rates of poly(dl-lactide-co-glycolide) microcapsules","volume":"22","author":"Visscher","year":"1988","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0250","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jbm.820190315","article-title":"Biodegradation of and tissue reaction to 50:50 poly(dl-lactide-co-glycolide) microcapsules","volume":"19","author":"Visscher","year":"1985","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0255","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0168-3659(01)00413-8","article-title":"Hydrophilic poly(dl-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells","volume":"76","author":"Walter","year":"2001","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0260","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/PRS.0000000000000287","article-title":"Sustained delivery of rhBMP-2 via PLGA microspheres: cranial bone regeneration without heterotopic ossification or craniosynostosis","volume":"134","author":"Wink","year":"2014","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0265","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.peptides.2013.06.005","article-title":"Exenatide-loaded PLGA microspheres with improved glycemic control: in vitro bioactivity and in vivo pharmacokinetic profiles after subcutaneous administration to SD rats","volume":"46","author":"Xuan","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.ijpharm.2014.12.014_bib0270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.22203\/eCM.v028a23","article-title":"Microsphere size influences the foreign body reaction","volume":"28","author":"Zandstra","year":"2014","journal-title":"Eur. Cell. Mater."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314009028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517314009028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T06:57:23Z","timestamp":1566111443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517314009028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":54,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0378517314009028"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.12.014","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biocompatibility of poly(d,l-lactic-co-hydroxymethyl glycolic acid) microspheres after subcutaneous and subcapsular renal injection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2014.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}